• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Moderate alcohol consumption associated with reduced incidence of type 2 diabetes among women with a history of gestational diabetes

byJake EngelandMichael Pratte
September 13, 2021
in Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Women with a history of gestational diabetes who consumed 5.0-14.9 g/day of alcohol demonstrated a reduced risk of type 2 diabetes development compared to those without any alcohol consumption.

2. Beer and wine, but not liquor, were associated with lowering the risk of type 2 diabetes incidence among women with gestational diabetes.

Evidence Rating Level: 2 (Good)

Study Rundown: Women with a history of gestational diabetes have an increased risk of developing type 2 diabetes (T2D). Several studies have demonstrated that light to moderate alcohol consumption may reduce the risk of T2D. However, it is not known whether alcohol consumption can reduce the risk of T2D in women with gestational diabetes. This prospective cohort study aimed to assess the associations between alcohol consumption and the risk of T2D development among women with a history of gestational diabetes. Participants were enrolled from the Nurses’ Health Study (NHSII), part of the Diabetes & Women’s Health Study. Women were separated into four groups based on alcohol consumption: no alcohol consumption (reference), 0.1-4.9 g/day, 5.0-14.9 g/day, and > 15.0 g/day. There were 4740 women (mean [SD] age: 38.2 [5.0] years) included with a median follow-up time of 24 years (IQR: 18-28 years). When adjusting for major dietary and lifestyle factors, women who consumed 5.0-14.9 g/day had decreased risk of T2D incidence (Hazard ratio [HR]: 0.45 [95% CI: 0.33-0.61]) compared to those who did not consume any alcohol. Those who consumed 0.1-4.9 g/day (HR: 0.87 [95% CI: 0.73-1.03]) or > 15.0 g/day (HR: 0.62 [95% CI: 0.37-1.04]) had similar risk of T2D development compared to women who did not consume alcohol. Furthermore, even after adjusting for body mass index, women who reported 5.0-14.9 g/day of alcohol consumption had reduced  incidence of T2D (HR: 0.59 [95% CI: 0.42-0.81]). Upon assessment of the type of alcohol consumption and the risk of T2D development, > 1 beer serving/week (HR: 0.49 [95% CI: 0.34-0.72]) and > 3 wine servings/week (HR: 0.56 [95% CI: 0.37-0.86]) demonstrated a reduced risk of T2D development in the multivariable analysis. However, liquor consumption was not associated with decreased T2D incidence. Overall, this large, prospective cohort study with long-term follow-up demonstrated that 5.0-14.9 g/day of alcohol consumption was associated with a reduced risk of T2D among women with gestational diabetes. Notably, this study was limited by screening bias; women who were more health-conscious visited physicians more often and were, therefore, more likely to receive a medical diagnosis of T2D.

Click to read the study in JAMA

Relevant Reading: Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis

RELATED REPORTS

Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

2 Minute Medicine Rewind March 23, 2026

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Alcoholalcohol consumptiongestational diabetesgestational diabetes (GDM)type 2 diabetesType 2 Diabetes Mellitus
Previous Post

Use of in vitro fertilization, twin pregnancies and advanced maternal age independently associated with adverse maternal outcomes

Next Post

Association of ECT with risks of all-cause mortality and suicide in older Medicare patients

RelatedReports

Sleep duration inversely related to childhood type 2 diabetes risk makers
Cardiology

Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial

April 3, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Weekly Rewinds

2 Minute Medicine Rewind March 23, 2026

March 23, 2026
Chronic Disease

Glucagon-like peptide-1 receptor agonists are associated with reduced risk of developing substance use disorders

March 9, 2026
Next Post

Association of ECT with risks of all-cause mortality and suicide in older Medicare patients

UTI associated with increased risk of preeclampsia

Preeclampsia across pregnancies and associated risk factors: findings from a high‐risk US birth cohort 

Bystander CPR positively associated with cardiac arrest survival

Adapted training program improves retention of Basic Life Support skills in young children

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Resuscitative endovascular balloon occlusion of the aorta may not improve outcomes in adults with non-traumatic out-of-hospital cardiac arrest
  • Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression
  • Utah launches first in nation pilot for autonomous artificial intelligence prescription renewals
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.